Based on the predominant stool type, assessed with the Bristol stool form scale (BSFS) (Lewis and Heaton, 1997), IBS patients can be categorized into four subgroups: IBS with predominant constipation (IBS-C), IBS with predominant diarrhea (IBS-D), IBS with mixed bowel habits (IBS-M), and unclassified IBS (IBS-U) (Lacy et al., 2016)
Week 78: Add 5-Amino-1MQ (5mg/day to start, increase to 1025mg/day based on tolerance) Running simultaneously (established protocol): If you're already on GLP-1 therapy and want to add the full stack, all four can be added simultaneously
The HGH alternatives guide compares peptide-based approaches against direct GH replacement
[1] [3] Other considerations during the perioperative period may include: Potential for nausea and vomiting Challenges with airway management if emergency intubation is required Effects on post-operative recovery and nutrition Changes in blood glucose control Anaesthetists may modify their approach based on individual risk assessment, potentially including techniques to reduce aspiration risk or additional monitoring